{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:35:20Z","timestamp":1793936120468,"version":"4.8.0"},"reference-count":56,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,1,31]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Targeted deletion of the gene for macrophage migration inhibitory factor (MIF) delays development of chronic lymphocytic leukemia and prolongs survival in mice. MIF recruits leukemia-associated macrophages to spleen or liver.<\/jats:p>","DOI":"10.1182\/blood-2012-05-431452","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T02:51:24Z","timestamp":1351824684000},"page":"812-821","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":97,"title":["Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor"],"prefix":"10.1182","volume":"121","author":[{"given":"Nina","family":"Reinart","sequence":"first","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Hien","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Boucas","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Rosen","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Michael","family":"Kvasnicka","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Heukamp","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Cologne, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Rudolph","sequence":"additional","affiliation":[{"name":"Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vangica","family":"Ristovska","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Velmans","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin S.","family":"Reiners","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke Pogge","family":"von Strandmann","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Krause","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Montesinos-Rongen","sequence":"additional","affiliation":[{"name":"Department of Neuropathology, University Hospital Cologne, Cologne, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Schlegelberger","sequence":"additional","affiliation":[{"name":"Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Herling","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hallek","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"},{"name":"Cologne Cluster of Excellence in Cellular Stress Responses in Aging-associated Diseases, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Fingerle-Rowson","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University Hospital Cologne, and Center for Integrated Oncology K\u00f6ln-Bonn, Cologne, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"24","key":"2019111816423665200_B1","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019111816423665200_B2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia.","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111816423665200_B3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia.","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111816423665200_B4","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V100.5.1795.h81702001795_1795_1801","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.","volume":"100","author":"Pedersen","year":"2002","journal-title":"Blood"},{"issue":"16","key":"2019111816423665200_B5","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies.","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111816423665200_B6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/sj.cdd.4401653","article-title":"MIF loss impairs Myc-induced lymphomagenesis.","volume":"12","author":"Talos","year":"2005","journal-title":"Cell Death Differ"},{"issue":"3","key":"2019111816423665200_B7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0090-4295(96)00207-5","article-title":"Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.","volume":"48","author":"Meyer-Siegler","year":"1996","journal-title":"Urology"},{"key":"2019111816423665200_B8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2407-7-135","article-title":"Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.","volume":"7","author":"Taylor","year":"2007","journal-title":"BMC Cancer"},{"issue":"3","key":"2019111816423665200_B9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lungcan.2004.05.013","article-title":"Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.","volume":"46","author":"Howard","year":"2004","journal-title":"Lung Cancer"},{"issue":"1","key":"2019111816423665200_B10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1073\/pnas.56.1.72","article-title":"Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction.","volume":"56","author":"David","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111816423665200_B11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0008-8749(83)90141-7","article-title":"Lymphokines and macrophages.","volume":"82","author":"David","year":"1983","journal-title":"Cell Immunol"},{"issue":"10","key":"2019111816423665200_B12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor: a regulator of innate immunity.","volume":"3","author":"Calandra","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"6544","key":"2019111816423665200_B13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production.","volume":"377","author":"Calandra","year":"1995","journal-title":"Nature"},{"issue":"5","key":"2019111816423665200_B14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","article-title":"MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.","volume":"13","author":"Bernhagen","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"2019111816423665200_B15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.immuni.2006.08.020","article-title":"CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.","volume":"25","author":"Shi","year":"2006","journal-title":"Immunity"},{"issue":"11","key":"2019111816423665200_B16","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","article-title":"MIF signal transduction initiated by binding to CD74.","volume":"197","author":"Leng","year":"2003","journal-title":"J Exp Med"},{"issue":"5","key":"2019111816423665200_B17","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M703265200","article-title":"Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex.","volume":"283","author":"Gore","year":"2008","journal-title":"J Biol Chem"},{"issue":"33","key":"2019111816423665200_B18","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","article-title":"IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival.","volume":"104","author":"Binsky","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111816423665200_B19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14728220903551304","article-title":"Autoimmune diseases: MIF as a therapeutic target.","volume":"14","author":"Greven","year":"2010","journal-title":"Expert Opin Ther Targets"},{"issue":"29","key":"2019111816423665200_B20","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.1101089108","article-title":"Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.","volume":"108","author":"Herrero","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111816423665200_B21","doi-asserted-by":"crossref","first-page":"e25259","DOI":"10.1371\/journal.pone.0025259","article-title":"MIF participates in Toxoplasma gondii-induced pathology following oral infection.","volume":"6","author":"Cavalcanti","year":"2011","journal-title":"PloS One"},{"issue":"9","key":"2019111816423665200_B22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00365540310016277","article-title":"Macrophage migration inhibitory factor and host innate immune responses to microbes.","volume":"35","author":"Calandra","year":"2003","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"2019111816423665200_B23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ni1571","article-title":"Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches.","volume":"9","author":"Sapoznikov","year":"2008","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111816423665200_B24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00019606-199802000-00008","article-title":"Expression of macrophage migration inhibitory factor in the human prostate.","volume":"7","author":"Meyer-Siegler","year":"1998","journal-title":"Diagn Mol Pathol"},{"issue":"5","key":"2019111816423665200_B25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.MP.0000068235.45178.C1","article-title":"Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.","volume":"16","author":"Legendre","year":"2003","journal-title":"Mod Pathol"},{"issue":"2","key":"2019111816423665200_B26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4049\/jimmunol.165.2.710","article-title":"Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells.","volume":"165","author":"Repp","year":"2000","journal-title":"J Immunol"},{"issue":"3","key":"2019111816423665200_B27","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-011-0858-3","article-title":"Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.","volume":"122","author":"Mittelbronn","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2019111816423665200_B28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.20111117","article-title":"Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.","volume":"209","author":"Schulz","year":"2012","journal-title":"J Exp Med"},{"issue":"4","key":"2019111816423665200_B29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1349-7006.2002.tb01269.x","article-title":"Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.","volume":"93","author":"Bando","year":"2002","journal-title":"Jpn J Cancer Res"},{"issue":"2","key":"2019111816423665200_B30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4049\/jimmunol.166.2.747","article-title":"Regulation of the CTL response by macrophage migration inhibitory factor.","volume":"166","author":"Abe","year":"2001","journal-title":"J Immunol"},{"issue":"10","key":"2019111816423665200_B31","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"2019111816423665200_B32","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1073\/pnas.1533295100","article-title":"The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting.","volume":"100","author":"Fingerle-Rowson","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111816423665200_B33","doi-asserted-by":"crossref","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","article-title":"IMGT, the international ImMunoGeneTics information system.","volume":"37","author":"Lefranc","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2019111816423665200_B34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-59745-409-4_30","article-title":"Spectral karyotyping and fluorescence in situ hybridization of murine cells.","volume":"506","author":"Rudolph","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"6","key":"2019111816423665200_B35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejcb.2011.08.006","article-title":"Role for CD74 and CXCR4 in clathrin-dependent endocytosis of the cytokine MIF.","volume":"91","author":"Schwartz","year":"2012","journal-title":"Eur J Cell Biol"},{"issue":"31","key":"2019111816423665200_B36","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1073\/pnas.0604564103","article-title":"B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia.","volume":"103","author":"Yan","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5434","key":"2019111816423665200_B37","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"issue":"49","key":"2019111816423665200_B38","doi-asserted-by":"crossref","first-page":"46877","DOI":"10.1074\/jbc.M207902200","article-title":"Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin- 4-ylethylamino)-quinoline-5,8-dione.","volume":"277","author":"Pu","year":"2002","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111816423665200_B39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"issue":"1","key":"2019111816423665200_B40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellsig.2003.07.002","article-title":"Mechanisms and effectors of MIF-dependent promotion of tumourigenesis.","volume":"16","author":"Mitchell","year":"2004","journal-title":"Cell Signal"},{"issue":"5","key":"2019111816423665200_B41","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1053\/j.gastro.2005.07.061","article-title":"Macrophage migration inhibitory factor promotes intestinal tumorigenesis.","volume":"129","author":"Wilson","year":"2005","journal-title":"Gastroenterology"},{"issue":"10","key":"2019111816423665200_B42","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.190.10.1375","article-title":"A proinflammatory cytokine inhibits p53 tumor suppressor activity.","volume":"190","author":"Hudson","year":"1999","journal-title":"J Exp Med"},{"issue":"2","key":"2019111816423665200_B43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molcel.2004.11.052","article-title":"Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway.","volume":"17","author":"Petrenko","year":"2005","journal-title":"Mol Cell"},{"issue":"12","key":"2019111816423665200_B44","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1182\/blood-2010-02-271171","article-title":"Phosphatidylinositol 3-kinase-delta inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals.","volume":"116","author":"Herman","year":"2010","journal-title":"Blood"},{"issue":"1","key":"2019111816423665200_B45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2007-09-111344","article-title":"Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy.","volume":"112","author":"Muzio","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111816423665200_B46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.03.005","article-title":"Macrophage migration inhibitory factor: a probable link between inflammation and cancer.","volume":"26","author":"Bucala","year":"2007","journal-title":"Immunity"},{"issue":"4","key":"2019111816423665200_B47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/jid.2010.418","article-title":"Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation.","volume":"131","author":"Yoshihisa","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2019111816423665200_B48","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/art.30203","article-title":"Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice.","volume":"63","author":"Santos","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2019111816423665200_B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2007.07.004","article-title":"The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.","volume":"66","author":"Allavena","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"2019111816423665200_B50","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1182\/blood-2007-05-089409","article-title":"Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.","volume":"110","author":"Burkle","year":"2007","journal-title":"Blood"},{"issue":"20","key":"2019111816423665200_B51","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood-2011-12-395939","article-title":"RhoH is critical for cell-microenvironment interactions in chronic lymphocytic leukemia in mice and humans.","volume":"119","author":"Troeger","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2019111816423665200_B52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"21","key":"2019111816423665200_B53","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells.","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111816423665200_B54","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111816423665200_B55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2567.1997.00311.x","article-title":"Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion.","volume":"92","author":"Onodera","year":"1997","journal-title":"Immunology"},{"issue":"6","key":"2019111816423665200_B56","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1359\/jbmr.060310","article-title":"Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.","volume":"21","author":"Onodera","year":"2006","journal-title":"J Bone Miner Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/5\/812\/1369895\/zh800513000812.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/5\/812\/1369895\/zh800513000812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T16:43:03Z","timestamp":1574095383000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/5\/812\/31400\/Delayed-development-of-chronic-lymphocytic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,1,31]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-05-431452","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}